Skip to main content

Table 3 GSTO1*A140D and GSTO*2N142D genotypes and allele distribution in the ALL cases, de novo ALL cases, and control groups

From: The role of glutathione S-transferase omega gene polymorphisms in childhood acute lymphoblastic leukemia: a case-control study

 

ALL cases [N = 96]

De novo cases [N = 46]

Controls [N = 99]

P value

OR (95% CI)

GSTO1 genotypes

CC

43 (44.8%)

17 (37%)

56 (56.6%)

0.106a

0.008b

 

CA

45 (46.9%)

22 (47.8%)

40 (40.4%)

AA

8 (8.3%)

7 (15.2%)

3 (3.0%)

CA + AA

53 (55.8%)

29 (63%)

43 (43.4%)

0.085a

1.643(0.932–2.898)a

0.028b

2.222 (1.083–4.558)b

Alleles

C

131 (68.2%)

56 (60.9%)

152 (76.8%)

Reference

A [minor allele]

61 (31.77%)

36 (39.1%)

46 (23.2%)

0.051a

1.563(0.997–2.448)a

0.005b

2.124 (1.24–3.620)b

GSTO2 genotypes

AA

25 (26.0%)

17 (37%)

36 (36.3%)

0.017a

0.002b

 

AG

60 (62.5%)

21 (45.7%)

61 (61.6%)

GG

11 (11.4%)

8 (17.3%)

2 (2.0%)

AG + GG

71 (73.9%)

29 (63.0%)

63 (63.6%)

0.132a

1.600(0.866–2.955)a

0.945b

0.975 (0.472–2.013)b

Alleles

A

111 (57.8%)

55 (59.8%)

133 (67.2%)

Reference

G [minor allele]

81 (42.2%)

37 (40.2%)

65 (32.8%)

0.046a

1.521(1.006–2.298)a

0.220b

1.37 (0.825–2.296)b

  1. P value < 0.05 is considered significant
  2. aALL cases and controls
  3. bDe novo cases and controls